This group also reported a correlation between a higher percentage of TIM-3 expression on HSCs in MDS patients and an increased WPSS score, greater than one cytopenia lineage, higher blast counts in bone marrow smears, and worse karyotype (21). The gene discussed is HAVCR2; the disease is myelodysplastic syndrome.